Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes.
about
Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and WomenAntioxidant effect of melatonin on the functional activity of colostral phagocytes in diabetic women.Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagonTired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story?A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Experimental and clinical aspects of melatonin and clock genes in diabetes.Phosphorylation of cyclic AMP-response element-binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β-cells (INS-1).Melatonin: an adjunctive treatment for cardiometabolic disease?Differences in circadian time structure of diastolic blood pressure between diabetes mellitus and essential hypertension.Effects of insulin on norepinephrine- and acetylcholine-induced membrane currents of pinealocytes from healthy Wistar and type 2 diabetic GK rats.Melatonin and selenium reduce plasma cytokine and brain oxidative stress levels in diabetic rats.
P2860
Q28546709-8165CA2F-888E-4BDA-9120-424F33A04788Q34599706-0ADC01B2-3152-48E1-A8AF-1B87C0E9387FQ36820392-0BF71E96-2C34-49E7-BBDA-CEB8D4A7E97CQ38046779-56BB3B36-A69F-40D5-93E5-C06C5CCA5775Q38163844-D84750D1-E085-4790-9923-89627EDC112DQ38255794-AF31D9B8-346A-417C-9C4B-E8789F66A1DDQ38436840-3A69ABAB-8609-43B2-84EA-45A9DC463F3FQ39344288-A4E9F329-C4AF-4BE4-AE8E-71390770C644Q42325630-D073A4B3-215A-4870-A5C6-DC28541B501CQ42550367-4976B732-AEEA-47F9-93FD-265C38423A73Q44819899-A0632718-11FE-49D4-A61D-28AA7BDC91EAQ52151033-D551EA14-685B-4365-A36B-6E8EB081F113
P2860
Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@ast
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@en
type
label
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@ast
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@en
prefLabel
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@ast
Catecholamines are the key for ...... in type 1 and type 2 diabetes.
@en
P2093
P2860
P921
P1476
Catecholamines are the key for ...... in type 1 and type 2 diabetes
@en
P2093
D Wedekind
E Mühlbauer
P2860
P304
P356
10.1111/J.1600-079X.2011.00951.X
P577
2011-09-19T00:00:00Z